94 results
Page 3 of 5
6-K
EX-99.1
fd2ki9 vb
4 Mar 21
GALAPAGOS REPORTS PRIMARY ENDPOINT FOR THE ONGOING FILGOTINIB MANTA AND MANTA-RAy SAFETY STUDIES
6:05am
6-K
EX-99.1
m77pop
10 Feb 21
Current report (foreign)
11:31am
6-K
EX-99.1
pzjr txi9
21 Jan 21
Current report (foreign)
7:49am
6-K
EX-99.1
rtwp7hvtp e7gt3cp
6 Jan 21
Galapagos to present at 39th Annual J.P. Morgan Healthcare Conference
9:57am
6-K
EX-99.1
38u uddl1g33h
5 Jan 21
Selvita completes acquisition of Fidelta from Galapagos
7:00am
6-K
EX-99.1
2ee5v o943ep
15 Dec 20
Current report (foreign)
4:55pm
6-K
EX-99.1
ytrtciyxz9
3 Dec 20
Galapagos announces first dosing in MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
4:34pm
6-K
EX-99.1
xq9wim mvsc
30 Nov 20
Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial
5:10pm
6-K
EX-99.1
0ozgynby5m6 pw
24 Nov 20
Selvita to acquire Fidelta from Galapagos
7:05am
6-K
EX-99.1
kksj0wej hda6n
10 Nov 20
Current report (foreign)
6:05am
6-K
EX-99.1
24wt0r
6 Nov 20
Current report (foreign)
10:06am
6-K
EX-99.1
oor0qu xmljp
3 Nov 20
Current report (foreign)
6:00am
6-K
EX-99.1
svl47epb0r432c
27 Oct 20
Current report (foreign)
12:13pm
6-K
EX-99.1
bdwi o33k02d3
15 Oct 20
Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
5:27pm
6-K
EX-99.1
p2e5wc
13 Oct 20
Current report (foreign)
6:15am
6-K
EX-99.1
z0c 4wojr0mnnch
30 Sep 20
Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial
6:00am
6-K
EX-99.1
jgs3kyt5xwaps8rq6
28 Sep 20
Current report (foreign)
6:00am
6-K
EX-99.1
i2gw41t4mxt roml
25 Sep 20
Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis
6:05am
6-K
EX-99.1
0fktytui
26 Aug 20
Galapagos to present new insights in IPF and related clinical developments at the European Respiratory Society Congress
6:37am